Explore why INmune Bio, Inc. is a speculative Strong Buy for high-risk investors. Click for the upcoming catalysts that make ...

Bluebird Bio revised its agreement with Carlyle and SK Capital, adding a $5 per share cash option for stockholders ahead of ...

Chime is a technology company, not a bank,” the company said in its prospectus, noting it’s not a member of the U.S. Federal ...